Gut Microbiota and Bile Acids Mediate the Clinical Benefits of YH1 in Male Patients with Type 2 Diabetes Mellitus: A Pilot Observational Study

• Main Authors: Yueh-Hsiang Huang (Author), Yi-Hong Wu (Author), Hsiang-Yu Tang (Author), Szu-Tah Chen (Author), Chih-Ching Wang (Author), Wan-Jing Ho (Author), Yi-Hsuan Lin (Author), Geng-Hao Liu (Author), Pei-Yeh Lin (Author), Chi-Jen Lo (Author), Yuan-Ming Yeh (Author), Mei-Ling Cheng (Author)
• Format: Book
• Published: MDPI AG, 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Our previous clinical trial showed that a novel concentrated herbal extract formula, YH1 (<i>Rhizoma coptidis</i> and Shen-Ling-Bai-Zhu-San), improved blood glucose and lipid control. This pilot observational study investigated whether YH1 affects microbiota, plasma, and fecal bile acid...